Log in

NYSE:CBTCabot Stock Price, Forecast & News

$36.50
+0.78 (+2.18 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$35.84
Now: $36.50
$36.88
50-Day Range
$28.17
MA: $32.01
$37.72
52-Week Range
$20.00
Now: $36.50
$50.58
Volume234,700 shs
Average Volume454,733 shs
Market Capitalization$2.06 billion
P/E Ratio20.39
Dividend Yield3.84%
Beta1.76
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. Further, it provides cesium formate brines used as a drilling and completion fluid primarily in high pressure and high temperature oil and gas well construction; and fine cesium chemicals used in a range of industries and applications that include catalysts, doping agents, and brazing fluxes. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Read More
Cabot logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.3Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.31 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
CUSIP12705510
Phone617-345-0100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.34 billion
Cash Flow$6.58 per share
Book Value$19.63 per share

Profitability

Net Income$157 million

Miscellaneous

Employees4,500
Market Cap$2.06 billion
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive CBT News and Ratings via Email

Sign-up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter.

Cabot (NYSE:CBT) Frequently Asked Questions

How has Cabot's stock been impacted by COVID-19 (Coronavirus)?

Cabot's stock was trading at $29.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CBT shares have increased by 22.0% and is now trading at $36.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cabot?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cabot.

When is Cabot's next earnings date?

Cabot is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Cabot.

How were Cabot's earnings last quarter?

Cabot Corp (NYSE:CBT) issued its quarterly earnings results on Monday, May, 11th. The specialty chemicals company reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.08. The specialty chemicals company had revenue of $710 million for the quarter, compared to the consensus estimate of $752.33 million. Cabot had a net margin of 3.38% and a return on equity of 17.88%. The company's revenue for the quarter was down 15.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.99 EPS. View Cabot's earnings history.

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot declared a quarterly dividend on Friday, May 8th. Shareholders of record on Friday, May 29th will be given a dividend of $0.35 per share on Friday, June 12th. This represents a $1.40 annualized dividend and a dividend yield of 3.84%. The ex-dividend date is Thursday, May 28th. View Cabot's dividend history.

How will Cabot's stock buyback program work?

Cabot announced that its Board of Directors has authorized a share buyback plan on Monday, July 16th 2018, which allows the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 10.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.

What price target have analysts set for CBT?

9 equities research analysts have issued twelve-month price objectives for Cabot's stock. Their forecasts range from $31.00 to $52.00. On average, they expect Cabot's stock price to reach $38.63 in the next year. This suggests a possible upside of 5.8% from the stock's current price. View analysts' price targets for Cabot.

Has Cabot been receiving favorable news coverage?

Media coverage about CBT stock has been trending somewhat negative on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cabot earned a news sentiment score of -1.6 on InfoTrie's scale. They also gave news stories about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutCabot.

Are investors shorting Cabot?

Cabot saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 901,600 shares, an increase of 16.5% from the April 30th total of 774,100 shares. Based on an average daily trading volume, of 434,500 shares, the short-interest ratio is presently 2.1 days. Currently, 1.6% of the company's stock are short sold. View Cabot's Current Options Chain.

Who are some of Cabot's key competitors?

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Energy Transfer LP Unit (ET), Broadcom (AVGO), Pfizer (PFE), Intel (INTC), AT&T (T), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO), Chevron (CVX) and Walt Disney (DIS).

Who are Cabot's key executives?

Cabot's management team includes the following people:
  • Mr. Sean D. Keohane, Pres, CEO & Director (Age 52)
  • Ms. Erica McLaughlin, Sr. VP & CFO (Age 43)
  • Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 57)
  • Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 49)
  • Mr. Patrick M. Prevost, Advisor & Director (Age 64)

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (9.02%), Fuller & Thaler Asset Management Inc. (4.97%), Bank of New York Mellon Corp (4.04%), Wellington Management Group LLP (3.44%), Victory Capital Management Inc. (3.04%) and Victory Capital Management Inc. (3.04%). Company insiders that own Cabot stock include Brian A Berube, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View institutional ownership trends for Cabot.

Which major investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Principal Financial Group Inc., AJO LP, Bank of New York Mellon Corp, BlackRock Inc., Nuveen Asset Management LLC, Deutsche Bank AG, and UBS Group AG. View insider buying and selling activity for Cabot.

Which major investors are buying Cabot stock?

CBT stock was acquired by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Victory Capital Management Inc., Victory Capital Management Inc., Penn Capital Management Co. Inc., Deprince Race & Zollo Inc., Ensign Peak Advisors Inc, AQR Capital Management LLC, and Parametric Portfolio Associates LLC. View insider buying and selling activity for Cabot.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $36.50.

How big of a company is Cabot?

Cabot has a market capitalization of $2.06 billion and generates $3.34 billion in revenue each year. The specialty chemicals company earns $157 million in net income (profit) each year or $3.91 on an earnings per share basis. Cabot employs 4,500 workers across the globe.

What is Cabot's official website?

The official website for Cabot is www.cabot-corp.com.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.